The 8;21 translocation is one of the most common specific chromosomal rearrangements in acute myelogenous leukemia (AML). Our studies have led to the molecular cloning of the t(8;21) AML breakpoint and to the isolation of fusion transcripts. The chromosome 21 component of this fusion is derived from the AML1 gene, which we have found has striking similarity to the Drosophila segmentation gene, runt. The chromosome 8 gene, which we call ETO (for eight twenty-one), appears to be encoded over a large region of DNA (>0.5 megabase) with breakpoints occurring in a probable intron. We proposed to: 1) complete DNA sequence analysis of the fusion transcripts. In addition to the information gained regarding the potential functional significance of the fusion protein, we will use these data to develop PCR-based reagents for the sensitive detection of t(8;21) AML; 2) further characterize the AML1 and ETO genes. This will include the development of antibodies against the normal AML1 and ETO gene products for their use in immunocytochemical studies, as well as determination of the DNA sequence and chromosomal organization of the normal ETO gene, especially with regard to t(8;21) AML breakpoints; 3) investigate other leukemic translocation breakpoints involving 21q22.3, especially the 3;21 translocation associated with the blast crisis phase of CML and therapy-related myelodysplasia and acute leukemia.

Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Eleanor Roosevelt Institute for Cancer Research
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
R├ęgnier, Vinciane; Billard, Jean-Marie; Gupta, Sapna et al. (2012) Brain phenotype of transgenic mice overexpressing cystathionine ?-synthase. PLoS One 7:e29056
Moat, Stuart; Carling, Rachel; Nix, Authur et al. (2010) Multicentre age-related reference intervals for cerebrospinal fluid serine concentrations: implications for the diagnosis and follow-up of serine biosynthesis disorders. Mol Genet Metab 101:149-52
Nielsen, Darci M; Evans, Jeffrey J; Derber, William J et al. (2009) Mouse model of fragile X syndrome: behavioral and hormonal response to stressors. Behav Neurosci 123:677-86
Knox, Aaron J; Graham, Christine; Bleskan, John et al. (2009) Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis. Gene 429:23-30
Hoger, Joachim; Patterson, David; Hoger, Harald et al. (2009) Mice transgenic for reduced folate carrier: an animal model of Down syndrome? Amino Acids 36:349-57
Patterson, David; Graham, Christine; Cherian, Christina et al. (2008) A humanized mouse model for the reduced folate carrier. Mol Genet Metab 93:95-103
Pennington, Bruce F (2006) From single to multiple deficit models of developmental disorders. Cognition 101:385-413
Yao, Guimei; Chen, Xiao-Ning; Flores-Sarnat, Laura et al. (2006) Deletion of chromosome 21 disturbs human brain morphogenesis. Genet Med 8:1-7
Wenger, Galen R; Schmidt, Cecilia; Davisson, Muriel T (2004) Operant conditioning in the Ts65Dn mouse: learning. Behav Genet 34:105-19
Gardiner, Katheleen; Davisson, Muriel T; Crnic, Linda S (2004) Building protein interaction maps for Down's syndrome. Brief Funct Genomic Proteomic 3:142-56

Showing the most recent 10 out of 155 publications